Stocks  /  NASDAQ  /  PolyPid Ltd.

PolyPid Ltd.

Industry:   Health Care – Biotechnology: Pharmaceutical Preparations

Stock Symbol:   PYPD – NASDAQ

 

Animal Usage:   Animal Testing

Our Opinion

PolyPid Ltd. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of its medical analysis and clinical research.

Supporting Evidence:

The company stated in the following press release that they use animals for drug testing.

“PolyPid Ltd. announced that animal studies related to OncoPLEX, the Company’s lead intra-tumoral product candidate in oncology applied as a paste to the resection bed during surgery, have been published in an abstract in the American Society of Clinical Oncology 2022 Annual Meeting Abstract Book.” Read the following article

Company Description

PolyPid Ltd., a biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. The company has a research and development collaboration with ImmunoGenesis, Inc. for the development of formulations to treat solid tumors. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

Company Website: https://www.polypid.com

Contact:  IR@Polypid.com
Scroll to Top